Issuance was led by a $2 billion retail pricing from the University of California in the negotiated market and a $1.2 billion competitive deal from Washington.

Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $14.55 which represents a slight increase of $0.42 or 2.97% from the prior close of $14.13. The stock opened at $14.3 and ...

In a report released yesterday, Deane Dray from RBC Capital maintained a Sell rating on 3M (MMM – Research Report), with a price target of ...

RBC Capital analyst Mandeep Jagpal maintained a Sell rating on abrdn (ABDN – Research Report) today and set a price target of p135.00. The ...

Hedge funds have positioned for Donald Trump's U.S. presidency with their highest levels of borrowing since 2010, while ...

Underperforming since the calendar turned, "munis have continued to cheapen over the past three weeks as Treasury returns are about flat for the year while munis are down 0.31%," said Jason Wong, vice ...

U.S. stock-trading hedge funds kicked off the week with gross leverage levels in their highest range since 2010.

Morgan Stanley Wealth Management today announced results from its quarterly retail investor pulse survey: Majority of ...

T-Mobile Us Inc (TMUS) stock saw a modest uptick, ending the day at $218.97 which represents a slight increase of $3.22 or 1.49% from the prior close of $215.75. The stock opened at $219.21 and ...

Export Development Canada (EDC) stepped into the sterling on Monday to issue a new five year benchmark. “This was a good ...

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, ...

RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...